{"entity":{"id":"travera","kind":"company","name":"Travera","aka":[],"tldr":"Travera exposes a patient's living cancer cells to a broad range of approved drugs, including immunotherapies, and measures within days which ones the cells respond to.","summary":"Travera's Rapid Therapy Guidance evaluates a broad range of FDA-approved drug options against a patient's live tumour cells, measuring single-cell mass changes as a readout of drug response, and reports which options showed activity. Based in Medford, Massachusetts; physician-ordered.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://travera.com/"},{"label":"Listed on Future of Cancer Care Today (Sijbrandij Foundation)","url":"https://sijbrandijfoundation.org/fcct"}],"tags":["ctgov-sponsor","fcct-directory"],"related":[],"cancers":[],"sections":[],"technologies":["functional-drug-testing"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Medford, MA","country":"US","companyType":"diagnostics","website":"https://travera.com/","investors":[],"funding":[]},"route":"/companies/travera/","neighbours":{"technology":[{"id":"functional-drug-testing","kind":"technology","name":"Functional (ex vivo) drug testing","route":"/technologies/functional-drug-testing/"}]}}